M.Sc. Pia Roering - UTU Research Portal

Pia Roering
M.Sc.

Institute of Biomedicine (Faculty of Medicine)

piaroe@utu.fi

ORCID identifier: https://orcid.org/0000-0003-1650-0918

Publications

Novel therapy targets and biomarkers for high-grade serous carcinoma (2025) Roering, Pia
(G5 Article dissertation )
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status (2022)
- Frontiers in Oncology
Roering Pia, Siddiqui Arafat, Heuser Vanina D, Potdar Swapnil, Mikkonen Pia, Oikkonen Jaana, Li Yilin, Pikkusaari Sanna, Wennerberg Krister, Hynninen Johanna, Grenman Seija, Huhtinen Kaisa, Auranen Annika, Carpén Olli, Kaipio Katja
(A1 Refereed original research article in a scientific journal)
Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition (2021)
- Frontiers in Oncology
Siddiqui Arafat, Tumiati Manuela, Joko Alia, Sandholm Jouko, Roering, Aakko Pia Sofia, Vainionpää Reetta, Kaipio Katja, Huhtinen Kaisa, Kauppi Liisa, Tuomela Johanna, Hietanen Sakari
(A1 Refereed original research article in a scientific journal)
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors (2020)
- Journal of Pathology
Katja Kaipio, Ping Chen, Pia Roering, Kaisa Huhtinen, Piia Mikkonen, Päivi Östling, Laura Lehtinen, Naziha Mansuri, Taina Korpela, Swapnil Potdar, Johanna Hynninen, Annika Auranen, Seija Grénman, Krister Wennerberg, Sampsa Hautaniemi, Olli Carpén
(A1 Refereed original research article in a scientific journal)
Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses (2019)
- JCO Clinical Cancer Informatics
Isoviita VM, Salminen L, Azar J, Lehtonen R, Roering P, Carpén O, Hietanen S, Grénman S, Hynninen J, Färkkilä A, Hautaniemi S
(A1 Refereed original research article in a scientific journal)
A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients (2018)
- Clinical Cancer Research
Tumiati M, Hietanen S, Hynninen J, Pietilä E, Färkkilä A, Kaipio K, Roering P, Huhtinen K, Alkodsi A, Li Y, Lehtonen R, Erkan EP, Tuominen MM, Lehti K, Hautaniemi SK, Grénman S, Vähärautio A, Carpén O, Kauppi L
(A1 Refereed original research article in a scientific journal)
Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer (2018)
- Clinical Cancer Research
Isoviita VM, Salminen L, Azar J, Hynninen J, Lehtonen R, Roring P, Grenman S, Farkkila A, Hautaniemi S
(Other publication)
Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines. (2018)
- Clinical Cancer Research
Roering P, Mikkonen P, Potdar S, Wennerberg K, Hynninen J, Grenman S, Auranen A, Carpen O, Kaipio K
(Other publication)
(18)F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer (2016)
- Gynecologic Oncology
Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J
(A1 Refereed original research article in a scientific journal)
Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)
- Clinical Cancer Research
Kaipio K, Chen P, Huhtinen K, Mikkonen P, Ostling P, Mpindi JP, Lehtinen L, Roering P, Korpela T, Wennerberg K, Yadav B, Aittokallio T, Kulesskiy E, Hynninen J, Auranen A, Grenman S, Hautaniemi S, Carpen O
(Other publication)
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
- PLoS ONE
Laura Lehtinen, Pia Vesterkvist, Pia Roering, Taina Korpela, Liisa Hattara, Katja Kaipio, John-Patrick Mpindi, Johanna Hynninen, Annika Auranen, Ben Davidson, Caj Haglund, Kristiina Iljin, Seija Grenman, Harri Siitari, Olli Carpen
(A1 Refereed original research article in a scientific journal)
Characterization of primary high-grade serous ovarian cancer cell lines: Cell line and growth condition specific differences in stem cell marker expression and high-throughput drug screening (2013)
- Clinical Cancer Research
Roering P, Mikkonen P, Kaipio K, Huhtinen K, Hynninen J, Auranen A, Kulesskiy E, Yadav B, Aittokallio T, Grenman S, Wennerberg K, Carpen O
(Other publication)
Snorc is a novel cartilage specific small membrane proteoglycan expressed in differentiating and articular chondrocytes (2011)
- Osteoarthritis and Cartilage
Heinonen J, Taipaleenmaki H, Roering P, Takatalo M, Harkness L, Sandholm J, Uusitalo-Jarvinen H, Kassem M, Kiviranta I, Laitala-Leinonen T, Saamanen AM
(A1 Refereed original research article in a scientific journal)